Clinical Trials Browser

Recruiting × dabrafenib × 90 days × Clear all

NCT02693535 2026-03-19

TAPUR

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

NCT06475989 2026-03-02

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Phase 3 Recruiting

Refractory Differentiated Thyroid Gland Carcinoma

NCT07419932 2026-02-19

NeoLATC

Thyroid Neoplasms

NCT03340506 2026-02-03

Dabrafenib and/or Trametinib Rollover Study

Phase 4 Recruiting

CNSDermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

NCT06262919 2025-12-30

Special Drug Use-results Surveillance of Tafinlar/Mekinist

Recurrence